(Q64970716)

2 July 2019

title

Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. (English)

1 reference

2 July 2019

author

Anthony Tak-Cheung Chan

2

1 reference

2 July 2019

author name string

Teo PM

1

1 reference

2 July 2019

Lee WY

3

1 reference

2 July 2019

Leung TW

4

1 reference

2 July 2019

Johnson PJ

5

1 reference

2 July 2019

language of work or name

English

0 references

publication date

1 January 1999

1 reference

2 July 2019

International Journal of Radiation Oncology Biology Physics

published in

1 reference

2 July 2019

volume

43

1 reference

2 July 2019

issue

2

1 reference

2 July 2019

page(s)

261-271

1 reference

2 July 2019

A comparison of Ho's, International Union Against Cancer, and American Joint Committee stage classifications for nasopharyngeal carcinoma.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

The role of chemotherapy in the management of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

Nasopharynx carcinoma: choice of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

Re-irradiation of recurrent nasopharyngeal carcinoma--treatment techniques and results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900383-6

7 January 2021

10.1016/S0360-3016(98)00383-6

Identifiers

DOI

1 reference

2 July 2019

PubMed ID

10030248

1 reference

2 July 2019